How to Buy Abivax Sa Stock
Abivax Sa
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France.
Abivax Sa stock last closed at $82.28, down 4.18% from the previous day, and has increased 616.72% in one year. It has overperformed other stocks in the Biotechnology industry by 6.67 percentage points. Abivax Sa stock is currently +1,624.95% from its 52-week low of $4.77, and -11.44% from its 52-week high of $92.91.
At the moment, there are 63.42M ABVX shares outstanding. The market capitalization of ABVX is $5.22B. In the past 24 hours, 778,000 ABVX shares were traded.
How to Buy Abivax Sa Stock
Not sure how to invest in Abivax Sa stock? Here's how.
- Decide where to buy Abivax Sa stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you figure out where to buy Abivax Sa stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Choose your payment method and add your details.
- Analyze Abivax Sa stock: The Abivax Sa ticker symbol is ABVX. Is Abivax Sa stock a good investment? Should you buy shares of ABVX? How do ABVX's underlying business fundamentals look? Do top analysts think Abivax Sa is a good buy? Why has ABVX's stock price moved recently? (Hint: Our stock market research website can help you evaluate if ABVX is a good stock to buy).
- Place your ABVX purchase: Decide if you will purchase ABVX shares at the current market price or use a limit order to buy ABVX stock at a given price.
- Keep an eye on your investment in ABVX: Create a watchlist to track your position in Abivax Sa shares.
Step 1: Decide where to buy Abivax Sa stock
You will need a brokerage account to access the NASDAQ market and buy ABVX stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal information so you can buy ABVX today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to start your new brokerage account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've finished signing up on mobile trading apps, you need to deposit funds:
Watch the tutorial below if you need help transferring funds into your new brokerage account.
Step 4: Analyze Abivax Sa stock
Once you have figured out the best place to buy Abivax Sa stock, it's critical to research their stock before you buy, so you truly comprehend the risk as well as the upside.
Overview of key ABVX info
Abivax Sa Due Diligence Checks
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on ABVX's stock page.
Is ABVX stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge ABVX's intrinsic value.
You can access additional valuation research on ABVX's stock here.
ABVX Financial Summary
Signs that ABVX is financially healthy:
- There are more short-term assets than long-term liabilities on the ABVX balance sheet.
Signs that ABVX is not financially healthy:
- ABVX has cash burn of 158118604. It does not have sufficient cash and short-term investments to cover this.
- ABVX has $80.19M in cash and short term investments. This is not sufficient to cover its annual cash burn of $158.12M.
- ABVX debt to equity ratio of -3.48 is negative.
- ABVX profit margin has gone down from -1,932.5% to -2,530.6% in the past year.
- Total ABVX debt is still negative.
- There are more short-term liabilities than short-term assets on the ABVX balance sheet.
Is ABVX stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 7 Equities analysts who track ABVX, the consensus analyst rating on Abivax Sa is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Latest ABVX Analyst Forecasts
Yatin Suneja, a top 12% analyst from Guggenheim maintains ABVX with a strong buy rating and raises their ABVX price target from $50.00 to $101.00, on Jul 23, 2025.
Guggenheim's Yatin Suneja raised their price target on Abivax Sa (NASDAQ: ABVX) by 102% from $50 to $101 on 2025/07/23. The analyst maintained their Strong Buy rating on the stock.
On 20205/07/22, Abivax SA announced Phase 3 results from ABTECT 8-week induction trials investigating Obefazimod to treat ulcerative colitis, Suneja said, describing the results as "highly positive."
The results indicated "a profound dose response," which is "very encouraging from a regulatory standpoint," the analyst told readers.
Suneja said Obefazimod should be valued around $7B to $10B.
Jason Butler, a top 2% analyst from JMP Securities maintains ABVX with a buy rating and raises their ABVX price target from $33.00 to $95.00, on Jul 23, 2025.
You can dig deeper into what analysts are forecasting on the Abivax Sa stock forecast page.
ABVX Technical Indicators
ABVX Earnings
Last year, ABVX revenue was $8.98M. In the past two year, ABVX's revenue has grown by 34.73% per year. This was slower than the Biotechnology industry average of 67.22%.
Learn more about ABVX's earnings and revenue performance here.
What are ABVX executives and large shareholders up to?
Over the past 12 months, insiders at ABVX have not bought or sold any shares.
Get more info about who owns ABVX stock here.
Does ABVX provide a stable income stream?
No, Abivax Sa doesn't provide an income stream by paying out dividends.
What do other investors have to say about ABVX?
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your ABVX purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally the easiest way to buy. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a specific price, place a limit order.
Click the Open Trade button and eToro will place the order.
If you want additional help with buying stocks on eToro, watch the helpful video below:
Step 6: Keep an eye on your investment in ABVX
Now that you own some ABVX shares, you'll want to keep up with your new stock purchase.
Put ABVX on a watchlist to get notified of important updates regarding your ABVX stock.
ABVX Feed
How to Buy Stock in Abivax Sa
To reiterate, here are the 6 steps to buy Abivax Sa stock:
- Decide where to buy Abivax Sa stock
- Open your brokerage account
- Deposit money your investment account
- Analyze Abivax Sa stock
- Place your ABVX purchase
- Keep an eye on your investment in ABVX
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to watch your investment in Abivax Sa, get started below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.